Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Duddy

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Journal of Personalized Medicine|December 16, 2018
Personalized Medicine and Molecular Interaction Networks in Amyotrophic Lateral Sclerosis (ALS): Current KnowledgeStephen Morgan, Stephanie Duguez, William Duddy
Journal of Personalized Medicine|November 24, 2022
Genome-Wide Gene-Set Analysis Approaches in Amyotrophic Lateral SclerosisChristina Vasilopoulou, Stephanie Duguez, William Duddy
Skeletal Muscle|May 5, 2019
Muscle Gene Sets: a versatile methodological aid to functional genomics in the neuromuscular fieldApostolos Malatras, Stephanie Duguez, William Duddy
Expert Opinion on Biological Therapy|June 2, 2012
Exon skipping for nonsense mutations in Duchenne muscular dystrophy: too many mutations, too few patients?Toshifumi Yokota, William Duddy, Yusuke Echigoya, et al.
Expert Opinion on Biological Therapy|June 9, 2007
Potential of oligonucleotide-mediated exon-skipping therapy for Duchenne muscular dystrophyToshifumi Yokota, Emidio Pistilli, William Duddy, et al.
Journal of Neuromuscular Diseases|July 26, 2021
Optimized Molecular Interaction Networks for the Study of Skeletal MuscleStephen Morgan, Apostolos Malatras, Stephanie Duguez, et al.
F1000Research|December 13, 2021
snpQT: flexible, reproducible, and comprehensive quality control and imputation of genomic dataChristina Vasilopoulou, Benjamin Wingfield, Andrew P Morris, et al.
Plos One|March 28, 2015
In silico screening based on predictive algorithms as a design tool for exon skipping oligonucleotides in Duchenne muscular dystrophyYusuke Echigoya, Vincent Mouly, Luis Garcia, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 28, 2025
Direct Reprogramming of Human DMD Fibroblasts into Myotubes for In Vitro Evaluation of Antisense-Mediated Exon Skipping and Exons 45-55 Skipping Accompanied by Rescue of Dystrophin ExpressionJoshua A Lee, Takashi Saito, William Duddy, et al.
Journal of Personalized Medicine|December 1, 2020
What Can Machine Learning Approaches in Genomics Tell Us about the Molecular Basis of Amyotrophic Lateral Sclerosis?Christina Vasilopoulou, Andrew P Morris, George Giannakopoulos, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Journal of Personalized Medicine|December 16, 2018
Personalized Medicine and Molecular Interaction Networks in Amyotrophic Lateral Sclerosis (ALS): Current KnowledgeStephen Morgan, Stephanie Duguez, William Duddy
Journal of Personalized Medicine|November 24, 2022
Genome-Wide Gene-Set Analysis Approaches in Amyotrophic Lateral SclerosisChristina Vasilopoulou, Stephanie Duguez, William Duddy
Skeletal Muscle|May 5, 2019
Muscle Gene Sets: a versatile methodological aid to functional genomics in the neuromuscular fieldApostolos Malatras, Stephanie Duguez, William Duddy
Expert Opinion on Biological Therapy|June 2, 2012
Exon skipping for nonsense mutations in Duchenne muscular dystrophy: too many mutations, too few patients?Toshifumi Yokota, William Duddy, Yusuke Echigoya, et al.
Expert Opinion on Biological Therapy|June 9, 2007
Potential of oligonucleotide-mediated exon-skipping therapy for Duchenne muscular dystrophyToshifumi Yokota, Emidio Pistilli, William Duddy, et al.
Journal of Neuromuscular Diseases|July 26, 2021
Optimized Molecular Interaction Networks for the Study of Skeletal MuscleStephen Morgan, Apostolos Malatras, Stephanie Duguez, et al.
F1000Research|December 13, 2021
snpQT: flexible, reproducible, and comprehensive quality control and imputation of genomic dataChristina Vasilopoulou, Benjamin Wingfield, Andrew P Morris, et al.
Plos One|March 28, 2015
In silico screening based on predictive algorithms as a design tool for exon skipping oligonucleotides in Duchenne muscular dystrophyYusuke Echigoya, Vincent Mouly, Luis Garcia, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 28, 2025
Direct Reprogramming of Human DMD Fibroblasts into Myotubes for In Vitro Evaluation of Antisense-Mediated Exon Skipping and Exons 45-55 Skipping Accompanied by Rescue of Dystrophin ExpressionJoshua A Lee, Takashi Saito, William Duddy, et al.
Journal of Personalized Medicine|December 1, 2020
What Can Machine Learning Approaches in Genomics Tell Us about the Molecular Basis of Amyotrophic Lateral Sclerosis?Christina Vasilopoulou, Andrew P Morris, George Giannakopoulos, et al.
Pageof 4